
Standard Biotools Inc.
LABNasdaqCIK 1162194HealthcareFiscal year ends Dec 31
Reports and events: 345 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2022-11-0816:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-22-007235 |
| 2022-08-0916:28 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0001162194-22-000091 |
| 2022-08-0816:23 ET | 8-K | 2.02 Results of operations; 2.05 Exit or disposal costs; 9.01 Financial statements and exhibits | 0001171843-22-005465 |
| 2022-08-0511:13 ET | SC 13D/A | Ownership report, active investor, amended | 0000902664-22-003824 |
| 2022-08-0317:14 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001162194-22-000088 |
| 2022-07-0716:00 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001162194-22-000086 |
| 2022-06-2716:04 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001162194-22-000084 |
| 2022-06-1614:06 ET | 8-K | 5.07 Shareholder vote results | 0001162194-22-000067 |
| 2022-06-0710:31 ET | SC 13D/A | Ownership report, active investor, amended | 0000902664-22-003184 |
| 2022-05-0914:21 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0001162194-22-000055 |
| 2022-05-0516:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-22-003333 |
| 2022-05-0312:40 ET | SC 13D/A | Ownership report, active investor, amended | 0000902664-22-002749 |
| 2022-04-2917:23 ET | DEF 14A | Proxy statementPeriod 2022-06-15 | 0001162194-22-000050 |
| 2022-04-0817:07 ET | SC 13D | Ownership report, active investor | 0000950142-22-001358 |
| 2022-04-0517:07 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-096290 |
| 2022-03-2917:14 ET | SC 13D/A | Ownership report, active investor, amended | 0000902664-22-002331 |
| 2022-03-2909:35 ET | 8-K | 1.01 Entry into a material agreement; 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-22-087550 |
| 2022-03-2806:10 ET | 8-K | 1.01 Entry into a material agreement; 5.07 Shareholder vote results; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-085854 |
| 2022-03-1616:05 ET | 8-K | 5.02 Departure or appointment of officers or directors | 0001162194-22-000022 |
| 2022-03-0819:05 ET | 10-K | Annual reportPeriod 2021-12-31 | 0001162194-22-000021 |
| 2022-02-2416:45 ET | DEF 14A | Proxy statementPeriod 2022-03-25 | 0001193125-22-052230 |
| 2022-02-1818:30 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-22-001154 |
| 2022-02-1116:06 ET | 8-K/A | 9.01 Financial statements and exhibits | 0001193125-22-036985 |
| 2022-01-2417:24 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 3.03 Change to security holders’ rights; 5.02 Departure or appointment of officers or directors; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-22-016151 |
| 2022-01-1108:15 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-22-000217 |
| 2021-11-1817:28 ET | SC 13D | Ownership report, active investor | 0001567619-21-020773 |
| 2021-11-0920:23 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001162194-21-000087 |
| 2021-11-0816:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-21-007684 |
| 2021-09-0716:53 ET | 8-K | 2.03 New direct financial obligation | 0001193125-21-266704 |
| 2021-08-0616:24 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001162194-21-000072 |
| 2021-08-0516:22 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-21-005580 |
| 2021-08-0516:11 ET | 8-K | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001162194-21-000070 |
| 2021-05-2517:10 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001162194-21-000048 |
| 2021-05-1017:20 ET | SC 13D | Ownership report, active investor | 0000902664-21-002673 |
| 2021-05-0717:30 ET | 10-Q | Quarterly reportPeriod 2021-03-31 | 0001628280-21-009552 |
| 2021-05-0616:10 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-21-003265 |
| 2021-04-2916:56 ET | 8-K | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001162194-21-000034 |
| 2021-04-1417:14 ET | DEF 14A | Proxy statementPeriod 2021-05-25 | 0001162194-21-000020 |
| 2021-02-2514:21 ET | 10-K | Annual reportPeriod 2020-12-31 | 0001162194-21-000013 |
| 2021-02-1016:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-21-000919 |
| 2020-12-1516:50 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001162194-20-000118 |
| 2020-11-0918:30 ET | 10-Q | Quarterly reportPeriod 2020-09-30 | 0001162194-20-000107 |
| 2020-11-0516:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-20-007675 |
| 2020-09-2918:11 ET | 8-K | 1.01 Entry into a material agreement | 0001162194-20-000106 |
| 2020-09-0806:10 ET | 8-K | 8.01 Other events | 0001171843-20-006298 |
| 2020-08-0716:28 ET | 10-Q | Quarterly reportPeriod 2020-06-30 | 0001162194-20-000093 |
| 2020-08-0616:08 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001171843-20-005661 |
| 2020-06-2416:58 ET | 8-K | 5.02 Departure or appointment of officers or directors; 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001162194-20-000076 |
| 2020-05-1416:54 ET | DEF 14A | Proxy statementPeriod 2020-06-23 | 0001162194-20-000046 |
| 2020-05-1115:06 ET | 10-Q | Quarterly reportPeriod 2020-03-31 | 0001162194-20-000042 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 5, 2026, 21:16 ET. Listed shows no prices and gives no investment advice.